5482 related articles for article (PubMed ID: 3485703)
1. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
Murray JL; Dowd J; Hersh EM
J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin enhancement of immunocompetence in melanoma patients.
Tilden AB; Balch CM
Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
[TBL] [Abstract][Full Text] [Related]
3. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 production by mononuclear cells from patients with scleroderma.
Sandborg CI; Berman MA; Andrews BS; Friou GJ
Clin Exp Immunol; 1985 May; 60(2):294-302. PubMed ID: 3874022
[TBL] [Abstract][Full Text] [Related]
5. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
Tilden AB; Balch CM
Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
[TBL] [Abstract][Full Text] [Related]
6. Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.
Hudspith BN; Brostoff J; McNicol MW; Johnson NM
Clin Exp Immunol; 1984 Aug; 57(2):324-30. PubMed ID: 6331921
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
Miyasaka N; Murota N; Yamaoka K; Sato K; Yamada T; Nishido T; Okuda M
Clin Exp Immunol; 1986 Sep; 65(3):497-505. PubMed ID: 3490935
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic response and interleukin 2 production in Crohn's disease.
Miura M; Hiwatashi N
J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
[TBL] [Abstract][Full Text] [Related]
9. Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily.
Cillari E; Liew FY; Lo Campo P; Milano S; Mansueto S; Salerno A
J Immunol; 1988 Apr; 140(8):2721-6. PubMed ID: 3258620
[TBL] [Abstract][Full Text] [Related]
10. Production of interleukin 2 in multiple myeloma.
Commes T; Klein B; Jourdan M; Bataille R
Clin Exp Immunol; 1986 Mar; 63(3):533-40. PubMed ID: 3486731
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukins in viral inhibition of lymphocyte mitogenesis.
Wainberg MA; Roy S; Vydelingum S; Grise-Miron L
J Clin Lab Immunol; 1985 Dec; 18(4):167-74. PubMed ID: 3879502
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.
Goodwin JS; Messner RP
J Clin Invest; 1979 Aug; 64(2):434-9. PubMed ID: 457862
[TBL] [Abstract][Full Text] [Related]
13. Effect of the parasite enzyme, hypodermin A, on bovine lymphocyte proliferation and interleukin-2 production via the prostaglandin pathway.
Nicolas-Gaulard I; Moire N; Boulard C
Immunology; 1995 May; 85(1):160-5. PubMed ID: 7635517
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.
De A; Blotta HM; Mamoni RL; Louzada P; Bertolo MB; Foss NT; Moreira AC; Castro M
J Rheumatol; 2002 Jan; 29(1):46-51. PubMed ID: 11824970
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma.
Murray JL; Kollmorgen GM
J Clin Immunol; 1983 Jul; 3(3):268-76. PubMed ID: 6224806
[TBL] [Abstract][Full Text] [Related]
16. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract][Full Text] [Related]
18. Independence of depressed lectin-dependent cell-mediated cytotoxicity from interleukin 2 production in patients with systemic lupus erythematosus.
Perl A; González-Cabello R; Onody K; Bodó I; Gergely P
Clin Exp Immunol; 1986 Aug; 65(2):286-92. PubMed ID: 3491706
[TBL] [Abstract][Full Text] [Related]
19. Distinct role of neonatal and adult monocytes in the regulation of the in vitro antigen-induced plaque-forming cell response in man.
van Tol MJ; Zijlstra J; Thomas CM; Zegers BJ; Ballieux RE
J Immunol; 1984 Oct; 133(4):1902-8. PubMed ID: 6381591
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 response to arterial antigen, lipopolysaccharide, and oxidized low density lipoprotein in ischemic heart disease.
Grasing K; Rifici V; Patel M; Patel A; Dennis R; Kostis JB
J Investig Med; 1997 Oct; 45(8):474-82. PubMed ID: 9394101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
